BA
ZBH icon

Boston Advisors’s Zimmer Biomet ZBH Stock Holding History

Boston Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$7.68M Buy
57,660
+2,400
+4% +$310K 0.4% 61
2019
Q2 		$6.32M Sell
55,260
-13,612
-20% -$1.59M 0.34% 77
2019
Q1 		$8.54M Buy
+68,872
New +$7.83M 0.44% 54
2018
Q4 		– Sell
-2,012
Closed -$257K – 676
2018
Q3 		$257K Sell
2,012
-128
-6% -$15.2K 0.01% 593
2018
Q2 		$232K Buy
+2,140
New +$233K 0.01% 620
2018
Q1 		– Sell
-11,695
Closed -$1.37M – 676
2017
Q4 		$1.37M Sell
11,695
-546
-4% -$61.7K 0.03% 316
2017
Q3 		$1.39M Hold
12,241
– – 0.03% 323
2017
Q2 		$1.53M Buy
12,241
+5,477
+81% +$649K 0.04% 330
2017
Q1 		$802K Sell
6,764
-1,730
-20% -$196K 0.02% 387
2016
Q4 		$851K Sell
8,494
-9,234
-52% -$990K 0.02% 383
2016
Q3 		$2.24M Buy
17,728
+15,455
+680% +$1.91M 0.06% 276
2016
Q2 		$266K Sell
2,273
-907
-29% -$103K 0.01% 625
2016
Q1 		$329K Sell
3,180
-28
-0.9% -$2.71K 0.01% 558
2015
Q4 		$320K Buy
3,208
+87
+3% +$8.51K 0.01% 565
2015
Q3 		$285K Sell
3,121
-278
-8% -$27.9K 0.01% 672
2015
Q2 		$360K Buy
3,399
+72
+2% +$7.97K 0.02% 563
2015
Q1 		$380K Hold
3,327
– – 0.02% 529
2014
Q4 		$366K Buy
3,327
+58
+2% +$6.11K 0.02% 414
2014
Q3 		$319K Hold
3,269
– – 0.01% 446
2014
Q2 		$330K Hold
3,269
– – 0.01% 457
2014
Q1 		$300K Hold
3,269
– – 0.01% 468
2013
Q4 		$296K Sell
3,269
-124
-4% -$10.7K 0.01% 468
2013
Q3 		$271K Sell
3,393
-82
-2% -$6.46K 0.01% 453
2013
Q2 		$253K Buy
+3,475
New +$260K 0.01% 455

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Advisors's ZBH Position: Q3 2019 in Review

Boston Advisors increased its Zimmer Biomet (ZBH) stake by 4.3% in Q3 2019, buying an estimated $310K and bringing the position to 57,660 shares worth $7.68M. The position accounts for 0.4% of the portfolio, ranked #61.

Boston Advisors first reported a position in ZBH in Q2 2013 and has held it in 24 quarters since. The position peaked at $8.54M in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

  • Boston Advisors held 57,660 shares of Zimmer Biomet worth $7.68M as of Q3 2019.
  • Boston Advisors bought 2,400 Zimmer Biomet shares in Q3 2019, an estimated $310K.
  • Zimmer Biomet made up 0.4% of Boston Advisors's portfolio in Q3 2019, its #61 holding.
  • Boston Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 24 quarters since.
  • Boston Advisors's Zimmer Biomet position peaked at $8.54M in Q1 2019.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.